ArticleCancer medicine2026

Risk Factors and Comparative Safety of Anti-PD-1 Combination Therapies in Advanced Melanoma: A Nationwide Real-World Cohort Study From China.

Yuan Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.